Cargando…

Lichenoid Drug Eruption following Intravenous Application of Orally Formulated Diamorphine, a Semisynthetic Heroin

BACKGROUND: Lichen planus is a common skin disorder of unknown etiology. Most cases are idiopathic, but substances such as gold, antimalarials, penicillamine, thiazide diuretics, β-blockers, arsenic and nonsteroidal anti-inflammatory drugs have been implicated as trigger factors. CASE PRESENTATION:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolm, I., Eggmann, N., Kamarashev, J., Kerl, K., French, L.E., Hofbauer, G.F.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712815/
https://www.ncbi.nlm.nih.gov/pubmed/23874294
http://dx.doi.org/10.1159/000353305
_version_ 1782277116539174912
author Kolm, I.
Eggmann, N.
Kamarashev, J.
Kerl, K.
French, L.E.
Hofbauer, G.F.L.
author_facet Kolm, I.
Eggmann, N.
Kamarashev, J.
Kerl, K.
French, L.E.
Hofbauer, G.F.L.
author_sort Kolm, I.
collection PubMed
description BACKGROUND: Lichen planus is a common skin disorder of unknown etiology. Most cases are idiopathic, but substances such as gold, antimalarials, penicillamine, thiazide diuretics, β-blockers, arsenic and nonsteroidal anti-inflammatory drugs have been implicated as trigger factors. CASE PRESENTATION: We report the case of a lichenoid eruption in a male drug addict who administered oral heroin (diamorphine) intravenously. Diamorphine was stopped immediately. Following topical steroids, phototherapy and oral acitretin, the lesions gradually disappeared. A lymphocyte transformation test was negative for pure morphine and codeine. DISCUSSION: A coincidental association between the intravenous application of orally formulated semisynthetic heroin and the lichenoid eruption cannot be completely ruled out. However, the diagnosis of a lichenoid drug eruption is favoured over idiopathic lichen planus because of the clear chronological correlation between drug use and appearance as well as drug withdrawal and disappearance of the skin lesions, and because of a flare-up following repeated intravenous application of diamorphine.
format Online
Article
Text
id pubmed-3712815
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-37128152013-07-19 Lichenoid Drug Eruption following Intravenous Application of Orally Formulated Diamorphine, a Semisynthetic Heroin Kolm, I. Eggmann, N. Kamarashev, J. Kerl, K. French, L.E. Hofbauer, G.F.L. Case Rep Dermatol Published online: June, 2013 BACKGROUND: Lichen planus is a common skin disorder of unknown etiology. Most cases are idiopathic, but substances such as gold, antimalarials, penicillamine, thiazide diuretics, β-blockers, arsenic and nonsteroidal anti-inflammatory drugs have been implicated as trigger factors. CASE PRESENTATION: We report the case of a lichenoid eruption in a male drug addict who administered oral heroin (diamorphine) intravenously. Diamorphine was stopped immediately. Following topical steroids, phototherapy and oral acitretin, the lesions gradually disappeared. A lymphocyte transformation test was negative for pure morphine and codeine. DISCUSSION: A coincidental association between the intravenous application of orally formulated semisynthetic heroin and the lichenoid eruption cannot be completely ruled out. However, the diagnosis of a lichenoid drug eruption is favoured over idiopathic lichen planus because of the clear chronological correlation between drug use and appearance as well as drug withdrawal and disappearance of the skin lesions, and because of a flare-up following repeated intravenous application of diamorphine. S. Karger AG 2013-06-13 /pmc/articles/PMC3712815/ /pubmed/23874294 http://dx.doi.org/10.1159/000353305 Text en Copyright © 2013 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published online: June, 2013
Kolm, I.
Eggmann, N.
Kamarashev, J.
Kerl, K.
French, L.E.
Hofbauer, G.F.L.
Lichenoid Drug Eruption following Intravenous Application of Orally Formulated Diamorphine, a Semisynthetic Heroin
title Lichenoid Drug Eruption following Intravenous Application of Orally Formulated Diamorphine, a Semisynthetic Heroin
title_full Lichenoid Drug Eruption following Intravenous Application of Orally Formulated Diamorphine, a Semisynthetic Heroin
title_fullStr Lichenoid Drug Eruption following Intravenous Application of Orally Formulated Diamorphine, a Semisynthetic Heroin
title_full_unstemmed Lichenoid Drug Eruption following Intravenous Application of Orally Formulated Diamorphine, a Semisynthetic Heroin
title_short Lichenoid Drug Eruption following Intravenous Application of Orally Formulated Diamorphine, a Semisynthetic Heroin
title_sort lichenoid drug eruption following intravenous application of orally formulated diamorphine, a semisynthetic heroin
topic Published online: June, 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712815/
https://www.ncbi.nlm.nih.gov/pubmed/23874294
http://dx.doi.org/10.1159/000353305
work_keys_str_mv AT kolmi lichenoiddrugeruptionfollowingintravenousapplicationoforallyformulateddiamorphineasemisyntheticheroin
AT eggmannn lichenoiddrugeruptionfollowingintravenousapplicationoforallyformulateddiamorphineasemisyntheticheroin
AT kamarashevj lichenoiddrugeruptionfollowingintravenousapplicationoforallyformulateddiamorphineasemisyntheticheroin
AT kerlk lichenoiddrugeruptionfollowingintravenousapplicationoforallyformulateddiamorphineasemisyntheticheroin
AT frenchle lichenoiddrugeruptionfollowingintravenousapplicationoforallyformulateddiamorphineasemisyntheticheroin
AT hofbauergfl lichenoiddrugeruptionfollowingintravenousapplicationoforallyformulateddiamorphineasemisyntheticheroin